Brief: Inovio Announces New Data At Scientific Conferences For Lead Candidate, INO-3107, As A Potential Treatment For RRP

Inovio Pharmaceuticals

21/10/2024 13:41

Oct 21 (Reuters) - Inovio Pharmaceuticals Inc  INO.O :
    * INOVIO ANNOUNCES NEW DATA AT SCIENTIFIC CONFERENCES FOR
LEAD
CANDIDATE, INO-3107, AS A POTENTIAL TREATMENT FOR RRP
    * INOVIO PHARMACEUTICALS INC - INO-3107 WELL TOLERATED, 81%
OF
PATIENTS REQUIRED FEWER SURGERIES POST-TREATMENT
    * INOVIO PHARMACEUTICALS INC - 81% OF PATIENTS EXPERIENCED
FEWER
SURGICAL INTERVENTIONS POST-TREATMENT WITH INO-3107
    * INOVIO PHARMACEUTICALS INC - INO-3107 WELL TOLERATED, MOST
FREQUENT AES WERE INJECTION SITE PAIN AND FATIGUE

Source text for Eikon:  ID:nPn1KFrpsa 
Further company coverage:  INO.O